The Growth Potential of the Pharmacy Automation Systems Market

The pharmacy automation systems market in Europe is experiencing a tremendous growth spurt. Until recently, most pharmacies have been either without automation or have employed very basic automation systems. In response, the adoption rate of automation systems across Europe has been progressing from basic prescription management systems to advanced medication pick-up and drug dispensing automation systems. Likewise, although the adoption of automation systems has been most prevalent among hospital pharmacies, there is significant potential for growth in the retail pharmacy market across Europe.

New analysis from Frost & Sullivan (http://www.healthcareIT.frost.com), European Markets for Pharmacy Automation Systems, finds that the market earned revenues of $151.4 million in 2009 and estimates this to reach $360.2 million by 2016. This research service particularly focuses on prescription management automation systems, medication pick-up automation systems and drug dispensing automation systems.

"Pharmacy automation systems translate a product-centric pharmacy model into a patient-centric workflow model, thus improving the pharmacy environment for both the patients and the pharmacists," says Frost & Sullivan Industry Analyst S. Priyan. "More importantly, these systems reduce the waiting time for the patients, lower medication errors, prevent adverse drug events (ADE), and ease operating costs for the pharmacy, thereby enhancing patient safety, pharmacy productivity, and turnover."

There is considerable demand and potential for automation systems among retail pharmacies. Although the annual maintenance charges of automation systems are one of the least in the healthcare IT market in Europe, the revenues of pharmacy automation systems market are expected to more than double only by 2016.

However, diverse adoption characteristics among the various pharmacy groups in Europe result in slow market growth. Furthermore, the availability of varied information systems in the market for pharmacy workflows tends to confuse the end users, resulting in reduced penetration rates.

"There are several information systems available for pharmacy deployment in Europe such as pharmacy management systems, pharmacy information systems, and electronic prescribing systems," explains Priyan. "These systems reduce the market potential for advanced pharmacy automation systems as the end users make do with these basic workflow automation systems to meet the automation requirements of their pharmacy."

Standardising and consolidating delivery models for various pharmacy groups will help in increasing penetration rates. Organising workshops designed to educate end users on the systems' capabilities, and convening meetings to understand their requirements for offering customised solutions, will promote customer satisfaction, and thereby expand the customer base.

If you are interested in more information on this study, please send an e-mail to Katja Feick, Corporate Communications, at This email address is being protected from spambots. You need JavaScript enabled to view it. with your full name, company name, title, telephone number, company e-mail address, company website, city, state and country.

European Markets for Pharmacy Automation Systems is part of the Healthcare & Life Sciences IT Growth Partnership Services programme, which also includes research in the following markets: European Markets for Business Analytics in Healthcare, Electronic Medical Records Market in Europe, and Strategic Analysis of Care Management Market in Europe. All research services included in subscriptions provide detailed market opportunities and industry trends that have been evaluated following extensive interviews with market participants.

About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best-in-class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best-practice models to drive the generation, evaluation, and implementation of powerful growth strategies. Frost & Sullivan leverages over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from 40 offices on six continents. To join our Growth Partnership, please visit http://www.frost.com.

European Markets for Pharmacy Automation Systems (M567)

Most Popular Now

Philips Foundation 2024 Annual Report: E…

Marking its tenth anniversary, Philips Foundation released its 2024 Annual Report, highlighting a year in which the Philips Foundation helped provide access to quality healthcare for 46.5 million people around...

New AI Transforms Radiology with Speed, …

A first-of-its-kind generative AI system, developed in-house at Northwestern Medicine, is revolutionizing radiology - boosting productivity, identifying life-threatening conditions in milliseconds and offering a breakthrough solution to the global radiologist...

Scientists Argue for More FDA Oversight …

An agile, transparent, and ethics-driven oversight system is needed for the U.S. Food and Drug Administration (FDA) to balance innovation with patient safety when it comes to artificial intelligence-driven medical...

New Research Finds Specific Learning Str…

If data used to train artificial intelligence models for medical applications, such as hospitals across the Greater Toronto Area, differs from the real-world data, it could lead to patient harm...

Giving Doctors an AI-Powered Head Start …

Detection of melanoma and a range of other skin diseases will be faster and more accurate with a new artificial intelligence (AI) powered tool that analyses multiple imaging types simultaneously...

Patients say "Yes..ish" to the…

As artificial intelligence (AI) continues to be integrated in healthcare, a new multinational study involving Aarhus University sheds light on how dental patients really feel about its growing role in...

AI Agents for Oncology

Clinical decision-making in oncology is challenging and requires the analysis of various data types - from medical imaging and genetic information to patient records and treatment guidelines. To effectively support...

Brains vs. Bytes: Study Compares Diagnos…

A University of Maine study compared how well artificial intelligence (AI) models and human clinicians handled complex or sensitive medical cases. The study published in the Journal of Health Organization...

'AI Scientist' Suggests Combin…

An 'AI scientist', working in collaboration with human scientists, has found that combinations of cheap and safe drugs - used to treat conditions such as high cholesterol and alcohol dependence...

Start-ups in the Spotlight at MEDICA 202…

17 - 20 November 2025, Düsseldorf, Germany. MEDICA, the leading international trade fair and platform for healthcare innovations, will once again confirm its position as the world's number one hotspot for...